Literature DB >> 7882618

Marked induction of gelatinases, especially type B, in host fibroblasts by human ovarian cancer cells in athymic mice.

E Miyagi1, H Yasumitsu, F Hirahara, Y Nagashima, H Minaguchi, K Miyazaki, M Umeda.   

Abstract

Two human ovarian adenocarcinoma cell lines, MCAS-3 and OVISE-3 were found to secrete little of any type of gelatinase in tissue culture. However, when these cell lines were implanted subcutaneously into nude mice the cyst fluids from the resultant tumors contained gelatinase A and/or B. The enzyme activities, especially of gelatinase B, were much higher in the malignant MCAS-3 tumors than in those of the less malignant OVISE-3 tumor cells. To elucidate the origin of gelatinase B in cyst fluids of the MCAS-3 tumors, murine skin fibroblasts (MSF) were isolated from a subcutaneous tumor in a nude mouse and tested for their proteinase secretion in culture. MSF cells, which secreted some gelatinase A and gelatinase B, were induced to secrete high levels of both enzymes, especially gelatinase B, by co-cultivation with MCAS-3 cells. In addition, gelatinase A activity was induced by incubation of MSF cells with the conditioned medium of either MCAS-3 or OVISE-3 cells, whereas gelatinase B was induced only with that of MCAS-3. Although cytokines or growth factors such as IL-1 beta, TGF-beta 1, TNF-alpha or EGF stimulated the secretion of gelatinases A and B from MSF cells, their effects on gelatinase B activity were far less than that of the MCAS-3 conditioned medium. These results indicate that the major part of gelatinase B activity in the cyst fluids of the ovarian tumors is secreted by host interstitial cells stimulated by tumor-derived humoral factors. Similar tumor cell-host cell interactions may be important in the production of various proteinases in other tumor types.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7882618     DOI: 10.1007/bf00133613

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  33 in total

1.  Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta.

Authors:  C M Overall; J L Wrana; J Sodek
Journal:  J Biol Chem       Date:  1989-01-25       Impact factor: 5.157

2.  Mr 92,000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells.

Authors:  E J Bernhard; R J Muschel; E N Hughes
Journal:  Cancer Res       Date:  1990-07-01       Impact factor: 12.701

3.  Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells.

Authors:  E J Bernhard; S B Gruber; R J Muschel
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

4.  Elevated levels of M(r) 92,000 type IV collagenase in human brain tumors.

Authors:  J S Rao; P A Steck; S Mohanam; W G Stetler-Stevenson; L A Liotta; R Sawaya
Journal:  Cancer Res       Date:  1993-05-15       Impact factor: 12.701

5.  Constitutive expression of a 92-kD gelatinase (type V collagenase) by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines.

Authors:  E N Unemori; M S Hibbs; E P Amento
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

6.  Tumor cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin, and 72-kDa gelatinase.

Authors:  H Kataoka; R DeCastro; S Zucker; C Biswas
Journal:  Cancer Res       Date:  1993-07-01       Impact factor: 12.701

7.  Molecular cloning and expression of the mouse 105-kDa gelatinase cDNA.

Authors:  H Tanaka; K Hojo; H Yoshida; T Yoshioka; K Sugita
Journal:  Biochem Biophys Res Commun       Date:  1993-02-15       Impact factor: 3.575

8.  Expression of 72 kilodalton type IV collagenase (gelatinase A) in benign and malignant ovarian tumors.

Authors:  H Autio-Harmainen; T Karttunen; T Hurskainen; M Höyhtyä; A Kauppila; K Tryggvason
Journal:  Lab Invest       Date:  1993-09       Impact factor: 5.662

9.  Induction of 103-kDa gelatinase/type IV collagenase by acidic culture conditions in mouse metastatic melanoma cell lines.

Authors:  Y Kato; Y Nakayama; M Umeda; K Miyazaki
Journal:  J Biol Chem       Date:  1992-06-05       Impact factor: 5.157

10.  Malignant cell-specific gelatinase activity in human endometrial carcinoma.

Authors:  M Takemura; C Azuma; T Kimura; Y Tokugawa; M Miki; M Ono; F Saji; O Tanizawa
Journal:  Cancer       Date:  1992-07-01       Impact factor: 6.860

View more
  6 in total

1.  Metastatic and non-metastatic colorectal cancer (CRC) cells induce host metalloproteinase production in vivo.

Authors:  S Mc Donnell; V Chaudhry; J Mansilla-Soto; Z S Zeng; W P Shu; J G Guillem
Journal:  Clin Exp Metastasis       Date:  1999-06       Impact factor: 5.150

2.  Elevated levels of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 during the acute phase of Kawasaki disease.

Authors:  Pong Kian Chua; Marian E Melish; Qigui Yu; Richard Yanagihara; Kara S Yamamoto; Vivek R Nerurkar
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

3.  Transforming growth factor-beta - and tumor necrosis factor-alpha -mediated induction and proteolytic activation of MMP-9 in human skin.

Authors:  Y P Han; T L Tuan; M Hughes; H Wu; W L Garner
Journal:  J Biol Chem       Date:  2001-04-10       Impact factor: 5.157

4.  Evidence for tumor-host cooperation in regulating MMP-2 expression in human colon cancer.

Authors:  D L Ornstein; J MacNab; K H Cohn
Journal:  Clin Exp Metastasis       Date:  1999-05       Impact factor: 5.150

5.  Induction of membrane-type matrix metalloproteinase 1 (MT1-MMP) expression in human fibroblasts by breast adenocarcinoma cells.

Authors:  M Polette; C Gilles; V Marchand; M Seiki; J M Tournier; P Birembaut
Journal:  Clin Exp Metastasis       Date:  1997-03       Impact factor: 5.150

6.  Effect of matrix metalloproteinase inhibitors on tumor growth and spontaneous metastasis.

Authors:  J G Conway; S J Trexler; J A Wakefield; B E Marron; D L Emerson; D M Bickett; D N Deaton; D Garrison; M Elder; A McElroy; N Willmott; A J Dockerty; G M McGeehan
Journal:  Clin Exp Metastasis       Date:  1996-03       Impact factor: 5.150

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.